Proficio Capital Partners LLC Regenxbio Inc. Transaction History

Proficio Capital Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$26.52 - $49.35 $305,961 - $569,350	-11,537 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$27.01 - $40.26 $864 - $1,288	32 Added 0.28%	11,537 $317,000
Q2 2020 Aug 14, 2020	SELL	$27.75 - $43.44 $416 - $651	-15 Reduced 0.13%	11,505 $424,000
Q4 2019 Feb 13, 2020	BUY	$34.54 - $44.87 $518 - $673	15 Added 0.13%	11,520 $472,000
Q2 2019 Aug 13, 2019	BUY	$42.0 - $59.29 $478,716 - $675,787	11,398 Added 10652.34%	11,505 $591,000
Q1 2019 May 13, 2019	BUY	$40.82 - $62.45 $4,367 - $6,682	107 New	107 $6,000

193

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $339M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.